The Symbiotic Relationship Between Fu's Subcutaneous Needling and Myology
Fu's Subcutaneous Needling (FSN), invented by Dr. Fu Zhonghua, is not just a therapeutic technique—it is the clinical cornerstone that helped define modern myology (the science of muscles) at the American Myology Association (AMA). FSN's focus on "identifying and resolving muscle（including skeletal muscle, smooth muscle and cardiac muscle） dysfunction"aligns perfectly with myology's mission to understand, diagnose, and treat muscle-related conditions. Together, they form a symbiotic partnership: FSN provides real-world clinical insights to advance myological research, while myology offers the scientific framework to validate and refine FSN's efficacy. This connection is at the heart of AMA's work to transform muscle health care globally.
How FSN Laid the Groundwork for Modern Myology
Before FSN, muscles were often viewed as " exclusive movement tools" in mainstream medicine, with little attention to their role as root causes of chronic conditions (e.g., pain, insomnia, digestive issues). Dr. Fu's development of FSN in 1996 changed this paradigm—by targeting the "superficial fascia" (the connective tissue that surrounds and supports muscles) and focusing on "Tightened Muscle" (TM), FSN revealed a critical truth: many seemingly unrelated symptoms stem from underlying muscle dysfunction. This clinical observation became the foundation of AMA's myology discipline, driving three key scientific insights:
A. Muscles as "Pathological Hubs": FSN's success in treating conditions like chronic neck pain, pelvic floor disorders, and even secondary insomnia proved that muscles are not just "symptom carriers"—they are active contributors to health and disease. For example, FSN's ability to relieve headache by releasing tense shoulder muscles demonstrated that "second-site pain" (symptoms far from the dysfunctional muscle) is a common myological phenomenon.
B. Fascia-Muscle Interaction: FSN's focus on the superficial fascia highlighted its role in muscle function. Myology research, built on this, now confirms that fascia stiffness or adhesions directly impair muscle contraction and blood flow—explaining why FSN's gentle "sweeping" movements (which release fascia restrictions) produce rapid relief.
C. Reperfusion Approach (RA) as a Healing Mechanism: FSN's practice of combining needling with targeted muscle movements (called "reperfusion approach") showed that restoring blood flow to ischemic muscles accelerates recovery. This insight led myology to prioritize "muscle perfusion" as a key metric in diagnosing and treating conditions like peripheral vascular-induced muscle ischemia.
How Myology Validates and Expands FSN's Clinical Impact
Myology, as advanced by AMA, does not just "explain" FSN—it strengthens its scientific credibility and expands its applications. By grounding FSN in muscle anatomy, physiology, and pathology, myology ensures FSN is not just a "technique" but an evidence-based therapy tailored to individual muscle conditions.
Key examples of this collaboration include:
Precision Diagnosis for FSN: Myology's detailed classification of muscle disorders (e.g., skeletal muscle strain, myofascial pain syndrome, smooth muscle dysfunction) helps FSN practitioners identify the "exact type of muscle dysfunction" driving a patient's symptoms. For instance, a patient with lower back pain might be diagnosed via myological assessment as having "lumbar erector spinae hypertonicity" (not just "back pain"), allowing the FSN practitioner to target the specific affected muscle with greater accuracy.
Expanding FSN Beyond Pain: Myology research has extended FSN's use beyond chronic pain to conditions linked to muscle dysfunction. For example, AMA's clinical studies show FSN can improve symptoms of smooth muscle disorders (e.g., irritable bowel syndrome, where intestinal smooth muscle spasms cause discomfort) by regulating muscle tension through the traction and oscillation in fascial manipulation. It also helps with insomnia secondary to muscle pain—by relieving tense neck/shoulder muscles, FSN improves sleep quality, a connection validated by myology's study of muscle-pain-sleep pathways.
Measurable Outcomes with Myological Tools:
Myology provides FSN with objective metrics to track success. Practitioners now use myological assessment tools (e.g., muscle strength grading via the MRC Scale, pressure pain threshold testing) to measure pre- and post-FSN improvements—ensuring patients and practitioners can see tangible progress (e.g., "shoulder muscle strength improved from Grade 3 to 5" or "pain threshold increased by 20%").
AMA's Role in Uniting FSN and Myology for Global Muscle Health
At AMA, FSN and myology are not separate initiatives—they are integrated into every program, from clinical care to education and research. This unity ensures that FSN practitioners are also "myology-informed," and myology researchers are grounded in real-world clinical needs. AMA's key efforts to advance this partnership include:
FSN Myology Certification: AMA's FSN training program now requires practitioners to complete myology coursework (covering muscle anatomy, pathology, and assessment) before certification. This ensures FSN is practiced not just "by the book" but with a deep understanding of "why" it works for specific muscle conditions.
Clinical Trials: FSN + Myology: AMA leads collaborative studies to test FSN's efficacy for rare or understudied muscle disorders. For example, a 2024 AMA trial found FSN reduced symptoms in 78% of patients with "post-polio syndrome muscle weakness"—a finding published in the future related Journal and grounded in myological analysis of "neuromuscular junction dysfunction."
FSN Myology Clinics: AMA's global Myology Clinics Network features "FSN Myology Centers" where practitioners use FSN alongside myological diagnostics (e.g., ultrasound for muscle thickness measurement, EMG for neuromuscular function) to deliver comprehensive care. These centers serve as models for how FSN and myology can work together to solve complex muscle-related health issues.
The Future of FSN & Myology: Advancing Muscle Health Together
As myology continues to expand our understanding of muscle function (e.g., the role of muscle microbiomes, age-related sarcopenia), FSN will evolve to address new clinical challenges. Conversely, FSN's clinical innovations will continue to inspire myology research—uncovering new truths about how muscles interact with other bodily systems.
Dr. Fu Zhonghua, AMA's founder, summarizes this partnership best: "FSN is the ‘hand' that touches patients, and myology is the ‘brain' that guides it. Together, they turn compassion into science—and science into better lives for those with muscle-related conditions."For AMA, this means a future where FSN and myology are standard in global muscle care—ensuring every patient with a muscle disorder has access to therapy that is both effective and rooted in science.
